BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1435671)

  • 21. Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 May; 25(5):714-21. PubMed ID: 7747725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project.
    Frankenfield DL; Rocco MV; Frederick PR; Pugh J; McClellan WM; Owen WF
    Am J Kidney Dis; 1999 Oct; 34(4):721-30. PubMed ID: 10516355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access of Native Americans to renal transplantation in Arizona and New Mexico.
    Narva A; Stiles S; Karp S; Turak A
    Blood Purif; 1996; 14(4):293-304. PubMed ID: 8873955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities.
    Correa-de-Araujo R; Stevens B; Moy E; Nilasena D; Chesley F; McDermott K
    Womens Health Issues; 2006; 16(2):44-55. PubMed ID: 16638521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minority advantage in diabetic end-stage renal disease survival on hemodialysis: due to different proportions of diabetic type?
    Medina RA; Pugh JA; Monterrosa A; Cornell J
    Am J Kidney Dis; 1996 Aug; 28(2):226-34. PubMed ID: 8768918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excess incidence of treatment of end-stage renal disease in Mexican Americans.
    Pugh JA; Stern MP; Haffner SM; Eifler CW; Zapata M
    Am J Epidemiol; 1988 Jan; 127(1):135-44. PubMed ID: 3276155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of ESKD Among Native Hawaiians and Pacific Islanders Living in the 50 US States and Pacific Island Territories.
    Xiang J; Morgenstern H; Li Y; Steffick D; Bragg-Gresham J; Panapasa S; Raphael KL; Robinson BM; Herman WH; Saran R
    Am J Kidney Dis; 2020 Sep; 76(3):340-349.e1. PubMed ID: 32387021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From the Centers for Disease Control and Prevention. Treatment, end-stage renal disease attributed to diabetes mellitus--United States, 1980-1989.
    JAMA; 1992 Dec; 268(21):3056. PubMed ID: 1433727
    [No Abstract]   [Full Text] [Related]  

  • 31. Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan.
    Dyck RF; Tan L
    CMAJ; 1994 Jan; 150(2):203-8. PubMed ID: 8287342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for end-stage renal disease among minorities.
    Ferguson R; Morrissey E
    Transplant Proc; 1993 Aug; 25(4):2415-20. PubMed ID: 8356618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic disparities in diabetic complications in an insured population.
    Karter AJ; Ferrara A; Liu JY; Moffet HH; Ackerson LM; Selby JV
    JAMA; 2002 May; 287(19):2519-27. PubMed ID: 12020332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations?
    Wyatt CM
    Kidney Int; 2017 Apr; 91(4):766-768. PubMed ID: 28314573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethnic disparity in outcomes for pediatric peritoneal dialysis patients in the ESRD Clinical Performance Measures Project.
    Atkinson MA; Neu AM; Fivush BA; Frankenfield DL
    Pediatr Nephrol; 2007 Nov; 22(11):1939-46. PubMed ID: 17876608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis.
    Owen WF
    Blood Purif; 1996; 14(4):278-85. PubMed ID: 8873953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race.
    Murthy BV; Molony DA; Stack AG
    J Am Soc Nephrol; 2005 Mar; 16(3):782-90. PubMed ID: 15677309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes-related end-stage renal disease in Missouri: trends and variations by age and race.
    Urriola-Acheson A; Sharp DJ; Kruse KH; Austin DE; Weaver A; Brownson RC
    Mo Med; 1994 Jun; 91(6):287-90. PubMed ID: 8052218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system.
    Derose SF; Rutkowski MP; Crooks PW; Shi JM; Wang JQ; Kalantar-Zadeh K; Kovesdy CP; Levin NW; Jacobsen SJ
    Am J Kidney Dis; 2013 Aug; 62(2):236-44. PubMed ID: 23499049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.